Ikena Oncology, Inc.
Indole AHR inhibitors and uses thereof
Last updated:
Abstract:
The present invention provides compounds useful as inhibitors of AHR, compositions thereof, and methods of using the same.
Status:
Grant
Type:
Utility
Filling date:
8 Apr 2020
Issue date:
14 Jun 2022